NITROGLYCERIN

Nitroglycerin is denser than water and has limited solubility in water, with reported density around 1.6 for the desensitized liquid material.
Nitroglycerins physical behavior can vary depending on whether it is present as pure material or in a stabilized, diluted or desensitized formulation. 
Nitroglycerin has a relatively low melting point compared with many ordinary organic solids.

CAS Number: 103-01-5
Molecular Formula: C8H9NO2
Molecular Weight: 151.16
EINECS Number: 203-070-2

Synonyms: glyceryl trinitrate (GTN), trinitroglycerin (TNG), glonoin, AURORA KA-3653;ANILINOACETIC ACID;H-PHENYLGLY-OH;N-PHENYLGLYCIN;N-PHENYL-GLY-OH;N-PHENYLAMINOACETIC ACID;N-ALPHA-AMINOPHENYLACETIC ACID;PH-GLY-OH

Nitroglycerin a glycine carrying an N-phenyl substituent.
Nitroglycerin is a nitrate ester of glycerol and is also known as glyceryl trinitrate or glycerol trinitrate.
Nitroglycerins molecular formula is C₃H₅N₃O₉ and its molecular weight is approximately 227.09 g/mol.

Nitroglycerin is identified by CAS No. 55-63-0 and has the IUPAC name 1,3-dinitrooxypropan-2-yl nitrate. 
Nitroglycerin should not be confused with nitro compounds that contain carbon-nitrogen bonds directly.
Nitroglycerin is a nitrate ester in which the hydroxyl groups of glycerol have been converted into nitrate ester groups.

This distinction is important because the nitrate ester structure is responsible for many of its characteristic chemical and energetic properties. 
The molecule contains three nitrate ester groups attached to a three-carbon glycerol framework.
Nitroglycerins structure can be represented as C₃H₅(ONO₂)₃, reflecting the three nitrate ester functionalities present in the molecule.

The high proportion of oxygen and nitrogen within this relatively small organic molecule contributes to its energetic behavior. 
Nitroglycerin is commonly described as a colorless to pale-yellow, viscous liquid when encountered in its liquid form.

The reported melting point for the desensitized material is approximately 56 °F, corresponding to about 13 °C.
Its physical state can therefore change significantly with temperature. 

Nitroglycerin is particularly well known for its extreme sensitivity to heat, shock and other forms of mechanical or thermal energy when present in an energetic form.
Pure or insufficiently desensitized nitroglycerin can undergo extremely rapid decomposition and explosion.
For this reason, commercial and industrial applications generally involve controlled formulations rather than casual handling of the pure compound. 

The energetic nature of nitroglycerin results from the combination of its nitrate ester groups and its molecular composition.
When it decomposes rapidly, the molecule can produce a large quantity of gaseous products from a comparatively small amount of liquid material.
This rapid conversion from condensed material to hot gases is responsible for its historical importance as an energetic compound.

Nitroglycerin has a long history in the development of explosives technology.
Nitroglycerin became particularly important after the nineteenth-century development of methods for incorporating it into more manageable explosive formulations.
Its historical importance is closely connected with the development of dynamite and other industrial blasting materials.

One of the most significant developments was the incorporation of nitroglycerin into absorbent materials to reduce the handling difficulties associated with the pure liquid.
This development led to dynamite and related formulations that were considerably more practical for industrial blasting than unconfined liquid nitroglycerin.
Nitroglycerin subsequently became an important component of various commercial energetic materials.

Nitroglycerin is also historically associated with blasting gelatin and related energetic compositions.
NIST lists names such as “blasting gelatin” and “blasting oil” among names historically associated with nitroglycerin.
These names reflect its long-standing role in energetic-material technology rather than indicating that all materials described by those terms consist of pure nitroglycerin. 

Nitroglycerin has an entirely different and medically important application as a pharmaceutical active ingredient.
In medicine, controlled doses of nitroglycerin are used because Nitroglycerin produces vasodilation.
This property makes it useful in the treatment and prevention of certain forms of angina and other cardiovascular conditions.

The medical action of nitroglycerin is associated with its conversion to nitric oxide-related signaling species in the body.
Nitric oxide activates pathways that increase cyclic guanosine monophosphate, leading to relaxation of vascular smooth muscle.
The resulting vasodilation can reduce cardiac workload and improve blood flow to the heart.

Pharmaceutical nitroglycerin is supplied in carefully controlled formulations rather than as an energetic bulk chemical.
Depending on the medicinal product, it may be formulated for sublingual, transdermal, topical or other controlled routes of administration.
The medical formulations are designed to deliver precise quantities of the active substance while maintaining appropriate stability and handling characteristics.

The difference between pharmaceutical and energetic nitroglycerin is important when discussing Nitroglycerin.
A medicinal product contains nitroglycerin in a controlled formulation and at a quantity intended for therapeutic administration.
Industrial energetic materials, in contrast, are engineered for entirely different purposes and are subject to specialized safety controls.

Nitroglycerin is also known by numerous alternative names and abbreviations.
Common chemical names include glyceryl trinitrate, glycerol trinitrate, glycerin trinitrate, trinitroglycerin, nitroglycerine and GTN.
NIST also lists pharmaceutical names and abbreviations including NTG and NG. 

The molecular structure of nitroglycerin gives it a relatively high oxygen content.
Nitroglycerins formula contains three carbon atoms, five hydrogen atoms, three nitrogen atoms and nine oxygen atoms.
This unusual elemental composition contributes to both its chemical reactivity and its energetic characteristics. 

Nitroglycerin has a calculated XlogP value of approximately 1.6 and a topological polar surface area of about 165 Ų.
PubChem also reports nine hydrogen-bond acceptors and no hydrogen-bond donors for the molecular structure.
These calculated properties help describe the polarity and molecular interactions of Nitroglycerin. 

Nitroglycerin has no conventional hydrogen-bond donor because its hydrogen atoms are attached to carbon rather than oxygen or nitrogen.
However, the numerous oxygen atoms associated with its nitrate ester groups provide several potential hydrogen-bond acceptor sites.
This contributes to the polar character of the molecule despite its relatively small carbon skeleton.

Nitroglycerin has a relatively low vapor pressure under ordinary conditions.
The reported vapor pressure for the desensitized liquid is approximately 0.0003 mmHg.
Although this means it is not a highly volatile liquid like many common organic solvents, exposure can still occur through handling of contaminated materials or formulations. 

Nitroglycerin undergoes decomposition rather than behaving like an ordinary liquid when exposed to sufficiently high temperatures.
Available data indicate decomposition beginning around 122–140 °F, approximately 50–60 °C, for the referenced material.
This thermal behavior is one reason temperature control is important wherever nitroglycerin-containing materials are handled. 

Nitroglycerin can be prepared chemically by nitrating glycerol to convert its three hydroxyl groups into nitrate ester groups.
This reaction requires carefully controlled industrial conditions because the product is an energetic material and the reaction itself can present significant hazards.
Modern production therefore depends on specialized equipment, process controls and strict safety procedures.

The chemical behavior of nitroglycerin is strongly influenced by its nitrate ester functionality.
Under suitable conditions, these groups can participate in decomposition and redox processes that release substantial amounts of energy.
This chemistry distinguishes nitroglycerin from ordinary glycerol and from many less energetic nitrate-containing organic compounds.

Nitroglycerin has also been important in the history of industrial chemistry because it demonstrated how a highly energetic laboratory compound could be incorporated into controlled commercial formulations.
The development of stabilized and desensitized forms allowed its properties to be utilized while reducing some of the handling difficulties associated with the pure liquid.
This development was an important step in the evolution of modern blasting technology.

From a pharmaceutical perspective, nitroglycerin is valuable because the same molecule that possesses energetic chemical characteristics also has powerful biological activity at very low therapeutic doses.
Its vasodilator properties have made it an established cardiovascular medicine for many decades.
Nitroglycerin therefore occupies an unusual position at the intersection of energetic materials chemistry and pharmaceutical chemistry.

Nitroglycerin is consequently a chemically and historically distinctive compound with two very different major areas of application.
Nitroglycerin is an energetic nitrate ester associated with explosives technology, while controlled pharmaceutical formulations use it as a vasodilator for cardiovascular treatment.
Its molecular formula, nitrate ester structure, physical sensitivity and biological activity explain why nitroglycerin remains an important substance in both industrial chemistry and medicine. 

Nitroglycerin belongs to the organic nitrate family and contains three nitrate ester functionalities within a single glycerol-derived molecule.
The three nitrate groups give the molecule a substantially different chemical character from glycerol itself.
This structural arrangement is also responsible for Nitroglycerin's unusual combination of energetic and pharmacological properties. 

The nitrate ester groups are connected to the carbon skeleton through oxygen atoms rather than through direct carbon–nitrogen bonds.
For this reason, nitroglycerin is chemically classified as a nitrate ester even though nitrogen is an important element in its molecular formula.
This distinction is useful when comparing nitroglycerin with nitroalkanes and other nitrogen-containing organic compounds.

Nitroglycerin is sometimes abbreviated as NG or GTN in scientific and medical literature.
The name glyceryl trinitrate is particularly common in pharmaceutical and chemical contexts.
Other names include glycerol trinitrate, trinitroglycerin and nitroglycerine. 

The molecule has a relatively small carbon framework but contains a large number of heteroatoms.
Its formula, C₃H₅N₃O₉, contains nine oxygen atoms for only three carbon atoms.
This high oxygen-to-carbon ratio is an important feature when considering its decomposition and energetic behavior.

Nitroglycerin is generally described as a colorless to pale-yellow liquid in its liquid form.
Nitroglycerin is viscous and considerably denser than water, while its solubility in water is relatively low.
PubChem reports that nitroglycerin is only slightly soluble in water and can be much more soluble in certain organic solvents. 

The physical behavior of nitroglycerin depends strongly on whether it is pure, diluted or desensitized.
Diluted formulations can have substantially different sensitivity and handling characteristics from concentrated material.
This distinction is particularly important because evaporation of a solvent from a dilute formulation can leave behind a much more sensitive residue. 

Nitroglycerin ointment can be applied in the anal region to reduce internal sphincter tone and pressure.
This application is used for the management of pain associated with chronic anal fissures. 

Transdermal nitroglycerin provides a slower and more sustained delivery of the active compound.
This type of formulation has historically been used for prevention of angina rather than for immediate treatment of an acute episode.
The difference illustrates how the same chemical can have different clinical roles depending on its method of administration. 

Intravenous nitroglycerin can be used when rapid and controllable vasodilation is required in a medical setting.
Clinical applications include selected cases of perioperative hypertension, acute heart failure and persistent angina under appropriate medical supervision.
Because intravenous administration can produce rapid changes in blood pressure, it requires careful clinical monitoring. 

Melting point: 121-123 °C (lit.)
Boiling point: 273.17 °C (rough estimate)
Density: 1.2023 (rough estimate)
Refractive index: 1.5810 (estimate)
Storage temp.: Store at RT.
Solubility: DMSO (Sparingly), Methanol (Slightly)
Form: Fine Powder
pKa: 1.83, 4.39 (at 25 °C)
Color: Ochre to yellow-brown
Water solubility: Moderately soluble
Merck: 14,7292
BRN: 509838
Major application: Peptide synthesis
InChI: 1S/C8H9NO2/c10-8(11)6-9-7-4-2-1-3-5-7/h1-5,9H,6H2,(H,10,11)
InChIKey: NPKSPKHJBVJUKB-UHFFFAOYSA-N
SMILES: OC(=O)CNc1ccccc1

Nitroglycerin has a distinctive chemical structure in which all three hydroxyl groups of glycerol are converted into nitrate ester groups.
This gives the molecule three –O–NO₂ functionalities attached to the same three-carbon backbone.
The resulting structure is responsible for both its energetic properties and its biological activity. 

Nitroglycerin is classified chemically as an organic nitrate rather than a conventional nitro compound.
This distinction is particularly important in pharmaceutical chemistry because organic nitrates can undergo metabolic reactions that generate nitric oxide-related signaling species.
Nitric oxide then activates guanylate cyclase and increases cyclic GMP, producing relaxation of vascular smooth muscle. 

Nitroglycerin has a molecular weight of 227.09 g/mol and a calculated exact mass of approximately 227.0026 Da.
Nitroglycerins calculated XlogP value is about 1.6, while its topological polar surface area is approximately 165 Ų.
The molecule has no hydrogen-bond donors and nine hydrogen-bond acceptors according to calculated molecular descriptors. 

The high number of oxygen atoms in nitroglycerin is notable for such a small organic molecule.
The three nitrate ester groups account for nine oxygen atoms and three nitrogen atoms within the molecular formula.
This oxygen-rich composition contributes to the rapid decomposition characteristics that distinguish nitroglycerin from ordinary organic liquids. 

Nitroglycerin is considerably denser than water.
Reported relative density values are approximately 1.6, with a value of about 1.593 at 20 °C reported in chemical databases.
This high density is one of its characteristic physical properties. 

The substance has relatively low vapor pressure compared with highly volatile organic solvents.
A vapor pressure of approximately 0.0003 mmHg has been reported at ordinary temperatures.
Despite its low volatility, occupational exposure can still occur through skin contact, inhalation and other routes. 

Pure nitroglycerin and desensitized nitroglycerin-containing formulations should be distinguished carefully.
Desensitization or dilution can substantially change the handling characteristics of the material.
For example, certain dilute solutions are designed to reduce sensitivity, whereas evaporation of the solvent can leave behind a much more hazardous energetic residue. 

The sensitivity of nitroglycerin is strongly dependent on its physical state and formulation.
Undesensitized material can be extremely sensitive to heat, shock and friction.
For this reason, the substance is not treated like an ordinary laboratory solvent or pharmaceutical ingredient when present outside its controlled medicinal formulation. 

Nitroglycerin has historically played an important role in the development of commercial explosives.
Nitroglycerin was incorporated into materials such as dynamite to make its energetic properties more practically usable.
This application established nitroglycerin as one of the historically important high-energy compounds in industrial chemistry.

Nitroglycerin has also been associated with blasting gelatin and other energetic formulations.
These applications depend on its rapid decomposition and release of energy rather than on its pharmaceutical properties.
Modern handling of such materials requires specialized industrial controls because uncontrolled exposure can present severe explosion hazards.

Nitroglycerin has been investigated for energetic applications beyond conventional blasting materials.
Historical chemical references have associated it with propellant and rocket-fuel technologies.
These applications again depend on its energetic decomposition rather than its biological activity. 

The pharmaceutical properties of nitroglycerin arise from an entirely different aspect of its chemistry.
After administration, it participates in metabolic pathways that produce nitric oxide or related reactive nitrogen species.
These species activate soluble guanylate cyclase and increase intracellular cyclic GMP, causing vascular smooth-muscle relaxation. 

Nitroglycerin predominantly produces venous dilation at therapeutic doses.
This increases peripheral venous pooling and reduces the amount of blood returning to the heart.
The resulting reduction in venous return decreases left ventricular preload and can reduce cardiac workload. 

Nitroglycerin can also produce arterial dilation.
This can reduce peripheral vascular resistance and arterial pressure, although its venous effects are generally more prominent.
The balance between these effects depends on dose, formulation and the clinical circumstances of administration. 

One of the best-established medical applications of nitroglycerin is the treatment of angina pectoris.
Sublingual formulations can provide rapid relief during an acute anginal episode or can be used for short-term prevention before activities that are known to provoke symptoms.
Other formulations, including transdermal preparations, are used primarily for prevention rather than immediate relief. 

Nitroglycerin has also been used in intravenous medical formulations.
Depending on the clinical situation, intravenous administration can be used for conditions such as perioperative hypertension, selected cases of acute heart failure and refractory angina under medical supervision.
These applications require carefully controlled dosing because excessive vasodilation can cause substantial hypotension. 

Topical nitroglycerin represents another pharmaceutical application of Nitroglycerin.
Certain topical preparations are used to relieve pain associated with chronic anal fissures.
This application relies on local smooth-muscle relaxation rather than on the explosive properties associated with concentrated nitroglycerin. 

Nitroglycerin is rapidly absorbed when administered sublingually.
Its onset of action through this route is reported to be approximately one to three minutes, making it suitable for rapid relief of anginal symptoms.
Its pharmacological effects through this route generally persist for a relatively short period. 

Nitroglycerin also undergoes rapid metabolism within the body.
Nitroglycerin is converted into dinitrate and mononitrate metabolites, some of which retain vasodilatory activity.
The parent compound has a short estimated half-life, generally reported in the range of one to four minutes after appropriate administration. 

Repeated occupational exposure to nitroglycerin can produce a characteristic physiological response.
Workers exposed to organic nitrates may initially experience headaches, dizziness, nausea and decreases in blood pressure.
NIOSH has reported that tolerance to the vasodilatory effects can develop after several days of repeated exposure. 

The development of tolerance does not mean that occupational exposure becomes harmless.
Continued exposure can still present cardiovascular risks, and abrupt changes in exposure conditions may produce significant physiological effects.
Appropriate industrial hygiene controls are therefore essential wherever occupational exposure is possible. 

Nitroglycerin has also been studied extensively because it combines strong chemical reactivity with pronounced biological activity.
The same molecular structure that permits rapid energetic decomposition also allows the molecule to participate in biological nitrate metabolism.
This unusual combination makes nitroglycerin an important example of how one chemical structure can have very different technological and medical applications.

Nitroglycerin's historical importance extends into the development of pharmaceutical chemistry.
Nitroglycerin was recognized as a treatment for angina in the nineteenth century, long before its molecular mechanism was fully understood.
Its continued use demonstrates the long-term significance of organic nitrate chemistry in cardiovascular medicine. 

Nitroglycerin is therefore much more than an explosive compound.
Nitroglycerin is simultaneously an organic nitrate, a historically important energetic material and an established vasodilator used in cardiovascular medicine.
Its unusual combination of physical sensitivity, chemical composition and pharmacological activity makes it one of the most distinctive compounds in both industrial and pharmaceutical chemistry. 

Nitroglycerin can exist in different physical conditions depending on temperature.
Its relatively low melting temperature means that it can be encountered as a liquid under ordinary warm conditions.
Temperature changes can therefore influence its viscosity, phase behavior and handling characteristics.

Nitroglycerin is not considered highly volatile in the same way as common organic solvents such as acetone or diethyl ether.
Its reported vapor pressure is relatively low under ordinary conditions.
Nevertheless, exposure can occur through skin absorption or contact with contaminated surfaces, which is particularly important because nitroglycerin is pharmacologically active.

Nitroglycerin has an unusual relationship between chemical stability and energetic sensitivity.
It can remain relatively stable under controlled conditions but can undergo extremely rapid decomposition when exposed to sufficiently energetic stimuli.
The decomposition produces gaseous products and releases substantial energy in a very short period.

The energetic behavior of nitroglycerin has historically made it important in explosives technology.
Its incorporation into controlled formulations helped enable practical use in mining, quarrying, construction and other industrial blasting applications.
These applications are based on specialized formulations and regulated handling rather than routine use of pure nitroglycerin. 

Nitroglycerin was particularly significant in the development of dynamite.
The historical development of dynamite demonstrated that a highly sensitive energetic liquid could be incorporated into a more manageable commercial material.
This development had a major impact on industrial excavation and blasting technology.

Nitroglycerin has also been associated historically with propellant chemistry.
Its energetic decomposition can generate a large quantity of hot gaseous products from a relatively small quantity of material.
For this reason, nitroglycerin has appeared in historical formulations involving propellants and other energetic compositions. 

Nitroglycerin also produces arterial and arteriolar relaxation.
This can decrease peripheral vascular resistance and reduce afterload on the heart.
Nitroglycerin can additionally dilate large epicardial coronary arteries, although the precise contribution of this effect to relief of exertional angina is less certain. 

Sublingual nitroglycerin is particularly useful because it is absorbed rapidly through tissues beneath the tongue.
The vasodilatory effect can begin approximately one to three minutes after administration, making this route suitable for rapid treatment of anginal symptoms.
The relatively short duration of action is consistent with the rapid metabolism of Nitroglycerin. 

Nitroglycerin is rapidly converted into metabolites after administration.
Its metabolism produces dinitrate and mononitrate compounds, some of which retain vasodilatory activity but are less potent than the parent compound.
The reported half-life of nitroglycerin itself is only a few minutes. 

Uses:
Nitroglycerin is a derivative of Glycine (G615990). 
Nitroglycerin is also sometimes coupled with Glycidyl methacrylate to create a surface active comonomer that promotes adhesive bonding of materials to hard tooth tissues.

Nitroglycerin is widely used in medicine as a nitrate vasodilator, particularly in the management of angina pectoris associated with coronary artery disease.
Nitroglycerins ability to relax vascular smooth muscle and increase nitric-oxide-mediated signaling makes it an important cardiovascular pharmaceutical. 
One of the best-established applications of nitroglycerin is the rapid relief of acute anginal chest pain.

Sublingual nitroglycerin preparations are designed to provide a rapid systemic effect because the drug is absorbed through the oral mucosa. 
Nitroglycerin can also be used for the short-term prevention of angina when an activity is expected to provoke chest discomfort.
This application takes advantage of its vasodilatory action to reduce the cardiovascular demand associated with exertion. 

Transdermal nitroglycerin is another pharmaceutical application, particularly for the prevention of recurrent angina rather than immediate treatment of an acute attack.
Patches and related controlled-release systems allow nitroglycerin to provide a more sustained vasodilatory effect. 
Nitroglycerin is also formulated for intravenous administration in selected hospital settings.

Intravenous preparations may be used for conditions such as perioperative hypertension, certain cases of acute heart failure associated with myocardial infarction, refractory angina, and controlled induction of intraoperative hypotension. 
Another medical application is the treatment of chronic anal fissure.
Topical nitroglycerin ointment is used to reduce the moderate to severe pain associated with chronic anal fissures through local nitrate-mediated smooth-muscle relaxation. 

The pharmaceutical use of nitroglycerin is based on its conversion to nitric-oxide-related signaling species within the body.
This ultimately increases cyclic GMP concentrations and promotes relaxation of vascular smooth muscle, producing vasodilation and changes in cardiac preload and afterload. 
Nitroglycerin has also had a major historical role in the explosives industry.

Because of its extremely energetic decomposition and high explosive sensitivity, it became an important component of dynamite and other industrial explosive materials. 
The development of dynamite significantly broadened the practical industrial use of nitroglycerin by providing a more manageable form of an otherwise highly sensitive energetic compound.
Historically, nitroglycerin-based explosives were associated with mining, quarrying, construction, excavation, and other activities requiring controlled rock fragmentation. 

Nitroglycerin has also been associated historically with blasting gelatin and related energetic formulations.
These applications illustrate the importance of nitroglycerin in the development of commercial blasting technologies during the nineteenth and twentieth centuries. 
Historical chemical records also identify nitroglycerin in connection with rocket-propellant applications.

Nitroglycerin s high energy content made it relevant to research and development involving energetic propulsion materials, although modern propulsion systems generally rely on other specialized energetic compositions. 
Another historical industrial application involved the use of nitroglycerin in connection with combating oil-well fires.
Nitroglycerin s energetic properties were exploited in specialized historical practices where conventional approaches to controlling underground or well-associated fires were difficult. 

Nitroglycerin is also encountered in pharmaceutical research as a representative organic nitrate compound.
Its well-characterized vasodilatory mechanism has made it an important reference compound in studies of nitric oxide signaling, vascular smooth-muscle relaxation, and cardiovascular pharmacology. 
In pharmaceutical manufacturing, nitroglycerin can be incorporated into different dosage forms depending on whether rapid or sustained vasodilation is required.

Examples include sublingual tablets, transdermal systems, intravenous preparations, and topical ointments. 
Nitroglycerin is also important historically in the development of nitrate-based cardiovascular medicines.
Its long-standing clinical use helped establish organic nitrates as an important therapeutic class for the management of ischemic heart disease. 

From an industrial chemistry perspective, nitroglycerin demonstrates how the same chemical can have very different applications depending on formulation and concentration.
Pharmaceutical products use carefully controlled formulations for therapeutic delivery, whereas historical industrial applications exploited its energetic properties in explosive materials. 

Nitroglycerin is pharmaceutical rather than general-purpose industrial use.
Its recognized medical applications include acute and preventive treatment of angina, selected hospital cardiovascular indications, and topical treatment associated with chronic anal fissure. 
Nitroglycerin has an unusual dual history as both an important cardiovascular medicine and a highly energetic industrial chemical.

Nitroglycerin s pharmaceutical value comes from controlled vasodilation, while its historical industrial importance comes from the large amount of energy released during rapid decomposition. 
Nitroglycerin has an important role in emergency and hospital-based cardiovascular medicine because its vasodilatory effect can be rapidly adjusted when administered in appropriate clinical formulations.
Intravenous nitroglycerin is used in selected situations involving perioperative blood-pressure control, acute myocardial infarction with heart failure, refractory angina, and controlled intraoperative hypotension. 

Another application of nitroglycerin is the management of cardiovascular conditions in which reducing cardiac preload and vascular resistance can provide therapeutic benefit.
Nitroglycerin s predominant venodilator action decreases venous return to the heart, helping reduce cardiac workload in appropriate clinical situations. 
Nitroglycerin has also been used in specialized cardiology settings to produce temporary vasodilation during certain diagnostic or interventional procedures.

Nitroglycerin s vasodilatory properties can be useful when transient relaxation of vascular smooth muscle is required under controlled medical supervision. 
Nitroglycerin has a particularly long history in cardiovascular medicine, with therapeutic use for angina dating back to the nineteenth century.
This historical importance contributed to the development of organic nitrate drugs as a major class of antianginal medicines. 

Nitroglycerin is also included in the WHO Model List of Essential Medicines as glyceryl trinitrate for the treatment of angina pectoris.
This reflects its continuing importance as an established medicine for cardiovascular disease. 
Different pharmaceutical formulations allow nitroglycerin to be used for different therapeutic objectives.

Sublingual products are associated with rapid treatment of anginal attacks, while transdermal systems are intended primarily for prevention of recurrent angina. 
Nitroglycerin also has applications in specialized topical pharmaceutical products.
Topical nitroglycerin ointment is indicated for moderate to severe pain associated with chronic anal fissure because local nitrate-mediated relaxation can reduce pressure and discomfort in the affected region. 

Beyond medicine, nitroglycerin has historically been one of the most significant energetic compounds used in commercial explosives.
Its high energy release led to its incorporation into dynamite and other industrial explosive materials. 
The historical use of nitroglycerin in dynamite was particularly important for industrial excavation and blasting technologies.

Nitroglycerin-based explosives were associated with activities such as mining, quarrying, construction, and rock excavation where controlled energy release was required. 
Nitroglycerin has also been documented as a component of blasting gelatin and related energetic materials.
These historical applications demonstrate the importance of nitrate esters in the development of commercial high-energy materials. 

Nitroglycerin has additionally been associated with historical rocket-propellant research and energetic propulsion applications.
Its high energy content made it relevant to early investigations into chemical energy sources for propulsion systems. 
Another historical use involved specialized applications for combating oil-well fires.

Nitroglycerin was documented in connection with these applications because its energetic characteristics could be exploited in highly specialized industrial operations. 
Nitroglycerin is also relevant to chemical and pharmaceutical research as a well-established nitrate vasodilator.
Researchers use it as a reference compound when investigating vascular smooth-muscle relaxation, nitric oxide signaling, and nitrate pharmacology. 

Nitroglycerins biological activity has also made nitroglycerin useful in research concerning cyclic GMP-dependent signaling pathways.
Nitroglycerin provides an established example of how an organic nitrate can produce physiological vasodilation through nitric-oxide-related mechanisms. 

Nitroglycerin therefore occupies an unusual position within industrial and pharmaceutical chemistry.
The same molecular structure has supported applications ranging from an essential cardiovascular medicine to historically important energetic materials. 
In modern commercial use, pharmaceutical applications represent the most recognizable controlled use of nitroglycerin outside specialized energetic industries.

Nitroglycerins established applications include treatment and prevention of angina, selected hospital cardiovascular indications, and topical treatment for chronic anal fissure. 
The industrial history of nitroglycerin also illustrates the importance of formulation in determining how an energetic chemical can be handled and utilized.
Commercial energetic applications historically relied on specially controlled formulations rather than treating pure nitroglycerin as an ordinary industrial chemical. 

Nitroglycerin has applications spanning cardiovascular medicine, pharmaceutical research, historical explosives technology, and specialized energetic-material research.
Its continuing medical importance and its major historical role in explosives make it one of the most distinctive compounds in industrial and pharmaceutical chemistry. 

Safety Profile:
Nitroglycerin is a highly hazardous energetic chemical because pure or insufficiently desensitized material can undergo explosive decomposition.
Nitroglycerin is particularly sensitive to heat, shock, friction, and other forms of physical disturbance, and NIOSH identifies it as an OSHA Class A explosive. 
The explosive hazard is one of the most important safety concerns associated with nitroglycerin.

Heating can cause violent combustion or explosive decomposition, while mechanical shock or friction can also initiate dangerous decomposition. 
Nitroglycerin can become especially hazardous if a desensitized or diluted formulation loses its stabilizing medium.
For example, certain nitroglycerin solutions can become increasingly shock-sensitive if the solvent evaporates and concentrated residue remains. 

Exposure to excessive heat presents a serious fire and explosion risk.
Nitroglycerin should therefore be kept away from ignition sources and conditions that could promote thermal decomposition. 

Nitroglycerin is also incompatible with several chemically reactive materials.
NIOSH identifies heat, ozone, shock, and acids as important incompatibilities, while PubChem also reports potentially vigorous reactions with certain reducing agents. 

In addition to its physical hazards, nitroglycerin has significant toxicological effects.
The reported exposure routes include inhalation, skin absorption, ingestion, and contact with the skin or eyes. 
Nitroglycerin can produce pronounced cardiovascular effects following excessive exposure.

Reported symptoms include headache, dizziness, flushing, nausea, vomiting, palpitations, and a significant decrease in blood pressure. 
Severe exposure can affect the central nervous system and cardiovascular system.
NIOSH lists the cardiovascular system, blood, skin, and central nervous system among the principal target organs associated with nitroglycerin exposure. 

Supply Of Nitroglycerin: 
For further information about Nitroglycerin, including available product grades, technical specifications, application suitability and supply options, please contact Ataman Kimya.